NSPR
InspireMD, Inc.NASDAQHealthcare$1.54-1.91%ClosedMarket Cap: $72.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.98
P/S
7.77
EV/EBITDA
-1.29
DCF Value
$-4.49
FCF Yield
-52.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.5%
Operating Margin
-552.6%
Net Margin
-543.3%
ROE
-116.2%
ROA
-70.3%
ROIC
-84.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $3.1M | 37.5% | $-12.1M | $-11.8M | $-0.14 | — |
| FY 2025 | $9.0M | 29.5% | $-49.1M | $-48.8M | $-0.76 | — |
| Q3 2025 | $2.5M | 34.2% | $-13.1M | $-12.7M | $-0.17 | — |
| Q2 2025 | $1.8M | 17.6% | $-13.0M | $-13.2M | $-0.26 | — |
| Q1 2025 | $1.5M | 19.1% | $-11.5M | $-11.2M | $-0.22 | — |
| Q4 2024 | $1.9M | 24.1% | $-9.4M | $-9.2M | $-0.19 | — |
| FY 2024 | $7.0M | 21.5% | $-33.5M | $-32.0M | $-0.76 | — |
| Q3 2024 | $1.8M | 22.9% | $-8.5M | $-7.9M | $-0.16 | — |
| Q2 2024 | $1.7M | 19.0% | $-8.3M | $-7.9M | $-0.22 | — |
| Q1 2024 | $1.5M | 19.3% | $-7.4M | $-7.0M | $-0.21 | — |
| Q4 2023 | $1.8M | 28.7% | $-5.8M | $-5.4M | $-0.25 | — |
| FY 2023 | $6.2M | 29.1% | $-21.1M | $-19.9M | $-0.82 | — |